VYNE Therapeutics Inc. (VYNE)

NASDAQ: VYNE · Real-Time Price · USD

1.420

+0.040 (2.90%)

At close: Jul 11, 2025, 4:00 PM

1.400

-0.020 (-1.41%)

After-hours: Jul 11, 2025, 7:44 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
Chronic Inflammatory and Immune-mediated Therapies	501.00K	Log In	Log In	Log In	Log In	Upgrade
Chronic Inflammatory and Immune-mediated Therapies Growth	18.16%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
United States	501.00K	Log In	Log In	Log In	Log In	Upgrade
United States Growth	18.16%	Log In	Log In	Log In	Log In	Upgrade